Jenni Björnulfson
Chief Executive Officer at LIDDS AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Carsten Nils Erik Browall | M | 66 | 13 years | |
| Johan Wachtmeister | M | 65 | 16 years | |
| Daniel Lifveredson | M | 48 | 7 years | |
| Bo Magnus Wahlström | M | 75 | 12 years | |
| Madeleine Lundberg | F | - | - | |
| Carl Philip Delborn | M | 49 | 8 years | |
| Mikael Olsson | M | 61 | 11 years | |
| Arne Ingemar Gladh | M | 74 | 3 years | |
| Lars-Inge Sjöqvist | M | 66 | - | |
| Stig Lennart Hansson | M | 68 |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Sven Peter Torbjörn Browall | M | 62 | - | |
| Sven Tobias Linebäck | M | 50 | - | |
| Torbjörn Mattias Koivisto | M | 55 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | 6 years |
| Niklas Axén | M | 61 | 20 years | |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | - |
| Ann-Kersti Adolfsson | F | 68 | - | |
| Christer Ahlberg | M | 53 |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | 3 years |
| Predrag Mitic | M | - | - | |
| Kia Bengtsson | F | - | 2 years | |
| Gunnar Ahlberg | M | 63 | 4 years | |
| Annika Alström | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Erik Magnusson | M | 63 |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | - |
| Marianne Dicander Alexandersson | F | 65 |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | - |
| Max Håkan Mitteregger | M | 61 | 1 years | |
| Kerstin Valinder-Strinnholm | F | 64 |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | - |
| Anders Månsson | M | 57 | 1 years | |
| Satyendra Kumar | M | 70 |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | - |
| Anja Peters Ohlsson | F | 54 | 2 years | |
| Johan Lund | M | 67 | - | |
| Matthew Lindon | M | 51 | 1 years | |
| Johan Georg Harmenberg | M | 70 | 2 years | |
| Ulrika Maria Wennberg | F | 54 |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | 11 years |
| Nina Herne | M | 55 | 1 years | |
| Gerd Inga-Lill Forslund Larsson | F | 70 | 7 years | |
| Anders Sigvard Bjartell | M | 65 | 7 years | |
| Charlotta Gauffin | M | 53 | 3 years | |
| Annette Møldrup | M | 63 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jenni Björnulfson
- Personal Network
